{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T07:06:12Z","timestamp":1784617572597,"version":"3.55.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010438","name":"Poznan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cyto.2026.157190","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:52:35Z","timestamp":1783630355000},"page":"157190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The significance of vascular endothelial growth factor and systemic inflammatory reaction in bladder cancer patients"],"prefix":"10.1016","volume":"205","author":[{"given":"Zofia","family":"Strojny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Kanikowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Kanikowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"Tomczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wies\u0142aw","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Strojny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"\u017buraszek-Szyma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Deja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Br\u0119borowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Korybalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2026.157190_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1453278","article-title":"Bladder cancer biomarkers: current approaches and future directions","volume":"14","author":"Ahangar","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cyto.2026.157190_bb0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s11912-023-01421-5","article-title":"An overview of angiogenesis in bladder Cancer","volume":"25","author":"Elayat","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.cyto.2026.157190_bb0015","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrurol.2011.145","article-title":"C-reactive protein as a biomarker for urological cancers","volume":"8","author":"Saito","year":"2011","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.cyto.2026.157190_bb0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definition Working Group","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cyto.2026.157190_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104352","article-title":"C-reactive protein (CRP) as a prognostic biomarker in patients with urothelial carcinoma: a systematic review and meta-analysis","volume":"197","author":"Fujiwara","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cyto.2026.157190_bb0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1158\/1055-9965.EPI-05-0626","article-title":"Plasma C-reactive protein and risk of cancer: a prospective study from Greece","volume":"15","author":"Trichopoulos","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cyto.2026.157190_bb0035","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0090-4295(94)80047-2","article-title":"Recovery of epidermal growth factor in voided urine of patients with bladder cancer","volume":"44","author":"Messing","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.cyto.2026.157190_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000079700","article-title":"Urinary basic fibroblast growth factor in bladder cancer patients. Histopathological correlation and clinical potential","volume":"73","author":"Gravas","year":"2004","journal-title":"Urol. Int."},{"key":"10.1016\/j.cyto.2026.157190_bb0045","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0022-5347(05)63999-7","article-title":"Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk","volume":"169","author":"Zhao","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.cyto.2026.157190_bb0050","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0022-5347(05)65752-7","article-title":"Serum levels of vascular endothelial growth factor as a prognostic factor in bladder cancer","volume":"166","author":"Bernardini","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.cyto.2026.157190_bb0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ssu.2980080507","article-title":"Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors","volume":"8","author":"Messing","year":"1992","journal-title":"Semin. Surg. Oncol."},{"key":"10.1016\/j.cyto.2026.157190_bb0060","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/onc.2017.375","article-title":"Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment","volume":"37","author":"Hsieh","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.cyto.2026.157190_bb0065","article-title":"First look at evaluation of serum angiopoietin-like 4 levels in bladder cancer: a pilot study","volume":"76","author":"Strojny","year":"2025","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.cyto.2026.157190_bb0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/biomedicines13010006","article-title":"Vascular endothelial growth factor (VEGF) family and the immune system: activators or inhibitors?","volume":"13","author":"Failla","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.cyto.2026.157190_bb0075","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/sj.bjc.6603923","article-title":"Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer","volume":"97","author":"Kut","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cyto.2026.157190_bb0080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000012095","article-title":"Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood","volume":"58","author":"Gunsilius","year":"2000","journal-title":"Oncology"},{"key":"10.1016\/j.cyto.2026.157190_bb0085","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1073\/pnas.94.2.663","article-title":"Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets","volume":"94","author":"M\u00f6hle","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cyto.2026.157190_bb0090","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/B:AGEN.0000029415.62384.ba","article-title":"Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor","volume":"6","author":"Kusumanto","year":"2003","journal-title":"Angiogenesis"},{"key":"10.1016\/j.cyto.2026.157190_bb0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13045-024-01528-7","article-title":"Targeting inflammation as cancer therapy","volume":"17","author":"Wang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cyto.2026.157190_bb0100","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.cyto.2012.10.024","article-title":"Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population","volume":"61","author":"Azimi-Nezhad","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2026.157190_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12032-019-1329-2","article-title":"The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications","volume":"37","author":"Tamura","year":"2019","journal-title":"Med. Oncol."},{"key":"10.1016\/j.cyto.2026.157190_bb0110","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2026.157190_bb0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41368-023-00231-6","article-title":"Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation","volume":"15","author":"Dongiovanni","year":"2023","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.cyto.2026.157190_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.105069","article-title":"Measuring salivary markers of inflammation in health research: a review of methodological considerations and best practices","volume":"124","author":"Szabo","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.cyto.2026.157190_bb0125","first-page":"597","article-title":"Weight loss-dependent and -independent effects of moderate calorie restriction on endothelial cell markers in obesity","volume":"68","author":"Korybalska","year":"2017","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.cyto.2026.157190_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10071018","article-title":"Moderate caloric restriction partially improved oxidative stress markers in obese humans","volume":"10","author":"Kanikowska","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.cyto.2026.157190_bb0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/00365510050185029","article-title":"Reference interval for serum C-reactive protein in healthy blood donors using the Dade Behring N latex CRP mono assay","volume":"60","author":"Erlandsen","year":"2000","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.cyto.2026.157190_bb0140","doi-asserted-by":"crossref","unstructured":"M.B. Pepys, G.M. Hirschfield, C-reactive protein: a critical update, J. Clin. Invest. 111 (2003) 1805\u20131812. doi:https:\/\/doi.org\/10.1172\/JCI18921. Erratum in: J. Clin. Invest. 112 (2003) 299.","DOI":"10.1172\/JCI200318921"},{"key":"10.1016\/j.cyto.2026.157190_bb0145","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4269\/ajtmh.20-0473","article-title":"Insights into the use of C-reactive protein as a diagnostic index of disease severity in COVID-19 infections","volume":"103","author":"Potempa","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.cyto.2026.157190_bb0150","series-title":"Advanced Statistics Using R","author":"Zhang","year":"2017"},{"key":"10.1016\/j.cyto.2026.157190_bb0155","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1023\/A:1021379811308","article-title":"A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful?","volume":"19","author":"Hormbrey","year":"2002","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.cyto.2026.157190_bb0160","unstructured":"E.C.I. Veerman, A. Vissink A, D.T. Wong, A. van Nieuw Amerongen, Processing and storage of saliva samples. In: Wong DT (ed) Salivary diagnostics, Wiley-Blackwell, Ames. (2008) 69\u201376. Chapter in Book, ISBN: 9780813813332."},{"key":"10.1016\/j.cyto.2026.157190_bb0165","series-title":"Salivary diagnostics","first-page":"37","article-title":"Saliva collectors","author":"Vissink","year":"2008"},{"key":"10.1016\/j.cyto.2026.157190_bb0170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12903-024-03902-w","article-title":"Extensive comparison of salivary collection, transportation, preparation, and storage methods: a systematic review","volume":"24","author":"Mortazavi","year":"2024","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.cyto.2026.157190_bb0175","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.archoralbio.2010.11.005","article-title":"Relation of salivary antioxidant status and cytokine levels to clinical parameters of oral health in pregnant women with diabetes","volume":"56","author":"Surdacka","year":"2011","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.cyto.2026.157190_bb0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3892\/br.2013.54","article-title":"Elevated serum levels of vascular endothelial growth factor is effective as a marker for malnutrition and inflammation in patients with ovarian cancer","volume":"1","author":"Watanabe","year":"2013","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.cyto.2026.157190_bb0185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2407-10-203","article-title":"Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer","volume":"10","author":"Kwon","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cyto.2026.157190_bb0190","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3892\/or_00000380","article-title":"Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancer","volume":"21","author":"Fauconnet","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cyto.2026.157190_bb0195","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1464-410X.2010.09543.x","article-title":"Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C","volume":"107","author":"Verma","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.cyto.2026.157190_bb0200","doi-asserted-by":"crossref","first-page":"362","DOI":"10.30699\/ijp.2021.138671.2518","article-title":"Significance of vascular endothelial growth factor expression in the bladder urothelial carcinoma and its association with tumor grade and invasiveness","volume":"16","author":"Sadaf","year":"2021","journal-title":"Iran. J. Pathol."},{"key":"10.1016\/j.cyto.2026.157190_bb0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12013-015-0574-z","article-title":"Bladder Cancer and genetic mutations","volume":"73","author":"Zhang","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.cyto.2026.157190_bb0210","first-page":"2381","article-title":"Expression of VEGF and its receptors VEGFR1\/VEGFR2 is associated with invasiveness of bladder cancer","volume":"33","author":"Kopparapu","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cyto.2026.157190_bb0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1758834016667179","article-title":"Incorporating VEGF-targeted therapy in advanced urothelial cancer","volume":"9","author":"Narayanan","year":"2016","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.cyto.2026.157190_bb0220","doi-asserted-by":"crossref","unstructured":"D.P. Petrylak, R. de Wit, K.N. Chi, A. Drakaki, C.N. Sternberg, H. Nishiyama, D. Castellano, S.A. Hussain, A. Fl\u00e9chon A, A. Bamias, E.Y. Yu, M.S. van der Heijden, N. Matsubara, B. Alekseev, A. Necchi, L. G\u00e9czi, Y.C. Ou, H.S. Coskun, W.P. Su, J. Bedke, G. Gakis, I.J. Percent, J.L. Lee, M. Tucci, A. Semenov, F. Laestadius, A. Peer, G. Tortora, S. Safina, X. Garcia Del Muro, A. Rodriguez-Vida, I. Cicin, H. Harputluoglu, S.T. Tagawa, U. Vaishampayan, J.B. Aragon-Ching, O. Hamid, A.M. Liepa, S. Wijayawardana, F. Russo, R.A. Walgren, A.H. Zimmermann, R.R. Hozak, K.M. Bell-McGuinn, T. Powles; RANGE study investigators, Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial, Lancet Oncol. 21 (2020) 105\u2013120. doi:https:\/\/doi.org\/10.1016\/S1470-2045(19)30668-0.","DOI":"10.1016\/S1470-2045(19)30668-0"},{"key":"10.1016\/j.cyto.2026.157190_bb0225","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.21.00286","article-title":"Randomized phase III trial of gemcitabine and cisplatin with bevacizumab or placebo in patients with advanced urothelial carcinoma: results of CALGB 90601 (Alliance)","volume":"39","author":"Rosenberg","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cyto.2026.157190_bb0230","first-page":"239","article-title":"The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy","volume":"6","author":"Aldebasi","year":"2013","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.cyto.2026.157190_bb0235","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2445781","article-title":"Prognostic and clinicopathological value of C-reactive protein in patients with bladder cancer: a meta-analysis","volume":"57","author":"Feng","year":"2025","journal-title":"Ann. Med."},{"key":"10.1016\/j.cyto.2026.157190_bb0240","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bjc.6606005","article-title":"Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer","volume":"104","author":"Volkova","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cyto.2026.157190_bb0245","first-page":"5139","article-title":"Prognostic impact of interleukin-6 and C-reactive protein on patients with breast cancer","volume":"17","author":"Shimura","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cyto.2026.157190_bb0250","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.21037\/atm-21-4097","article-title":"Development of nomograms related to inflammatory biomarkers to estimate the prognosis of bladder cancer after radical cystectomy","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.cyto.2026.157190_bb0255","doi-asserted-by":"crossref","first-page":"645","DOI":"10.7314\/APJCP.2013.14.2.645","article-title":"Prognostic value of tissue vascular endothelial growth factor expression in bladder cancer: a meta-analysis","volume":"14","author":"Huang","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.cyto.2026.157190_bb0260","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.atherosclerosis.2007.12.046","article-title":"C-reactive protein (CRP) increases VEGF-A expression in monocytic cells via a PI3-kinase and ERK 1\/2 signaling dependent pathway","volume":"200","author":"Bello","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2026.157190_bb0265","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3899\/jrheum.090941","article-title":"Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis","volume":"37","author":"Kurosaka","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cyto.2026.157190_bb0270","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/CS20070382","article-title":"Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease","volume":"115","author":"Valipour","year":"2008","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.cyto.2026.157190_bb0275","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3748\/wjg.v11.i8.1167","article-title":"Clinical significance of serum levels of vascular endothelial growth factor and its receptor in biliary disease and carcinoma","volume":"11","author":"Enjoji","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cyto.2026.157190_bb0280","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00404-005-0080-4","article-title":"Serum endometriosis","volume":"273","author":"Xavier","year":"2006","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.cyto.2026.157190_bb0285","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1186\/s12885-020-07415-x","article-title":"Clinical value of selected markers of angiogenesis, inflammation, insulin resistance and obesity in type 1 endometrial cancer","volume":"20","author":"Terlikowska","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cyto.2026.157190_bb0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cyto.2026.157190_bb0295","first-page":"2375","article-title":"Predictive values of serum VEGF and CRP levels combined with contrast enhanced MRI in hepatocellular carcinoma patients after TACE","volume":"6","author":"Li","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.cyto.2026.157190_bb0300","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.3390\/ijms22094483","article-title":"The interplay between oxidative stress, inflammation and angiogenesis in bladder Cancer development","volume":"22","author":"Wigner","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2026.157190_bb0305","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1464-410X.2007.07408.x","article-title":"C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy","volume":"101","author":"Yoshida","year":"2008","journal-title":"BJU Int."},{"key":"10.1016\/j.cyto.2026.157190_bb0310","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/07853890410026098","article-title":"Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis","volume":"36","author":"Caine","year":"2004","journal-title":"Ann. Med."},{"key":"10.1016\/j.cyto.2026.157190_bb0315","first-page":"4705","article-title":"White blood cell and platelet dynamics define human inflammatory recovery, medRxiv [Preprint]. 2021","volume":"13","author":"Foy","year":"2002","journal-title":"2021.06.19.21259181. Update in: Nat. Commun."},{"key":"10.1016\/j.cyto.2026.157190_bb0320","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1182\/blood.V98.9.2720","article-title":"Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis","volume":"98","author":"Kaser","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2026.157190_bb0325","doi-asserted-by":"crossref","first-page":"20187","DOI":"10.1038\/s41598-024-71186-9","article-title":"Subphenotypes of platelet count trajectories in sepsis from multi-center ICU data","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2026.157190_bb0330","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3892\/mco.2014.296","article-title":"Association between vascular endothelial growth factor gene polymorphisms and bladder cancer risk","volume":"2","author":"Yang","year":"2014","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.cyto.2026.157190_bb0335","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gene.2019.02.070","article-title":"Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: a systematic review and meta-analysis involving 6671 subjects","volume":"698","author":"Song","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.cyto.2026.157190_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155112","article-title":"Association between VEGF gene promoter polymorphisms and bladder cancer: an updated meta-analysis","volume":"131","author":"Chen","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2026.157190_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0030029","article-title":"Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk","volume":"3","author":"Garc\u00eda-Closas","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.cyto.2026.157190_bb0350","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cyto.2018.05.006","article-title":"Salivary fingerprint of simple obesity","volume":"11","author":"Lehmann-Kalata","year":"2018","journal-title":"Cytokines"},{"key":"10.1016\/j.cyto.2026.157190_bb0355","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-03565-9","article-title":"Increased MPO concentration but decreased peroxidase activity in saliva of obese women","volume":"15","author":"Korybalska","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2026.157190_bb0360","first-page":"1409","article-title":"Changes in salivary parameters of oral immunity after biologic therapy for inflammatory bowel disease","volume":"11","author":"Nijakowski","year":"2021","journal-title":"Life (Basel)."},{"key":"10.1016\/j.cyto.2026.157190_bb0365","article-title":"Treatment regimens and disease activity could alter salivary myeloperoxidase levels in patients with inflammatory bowel diseases","volume":"134","author":"Nijakowski","year":"2024","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.cyto.2026.157190_bb0370","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/ijerph14030281","article-title":"Oral health status of patients with lysosomal storage diseases in Poland","volume":"14","author":"Dr\u0105\u017cewski","year":"2017","journal-title":"Int. J. Environ. Res. Public Health"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:58:46Z","timestamp":1784617126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466626000852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":74,"alternative-id":["S1043466626000852"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157190","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The significance of vascular endothelial growth factor and systemic inflammatory reaction in bladder cancer patients","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"157190"}}